Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6, reflecting a minor backend or CMS update. No study details or user information were altered as part of this change.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small internal update to the page's version. This change does not affect the study details or visible content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This reflects a metadata update to the study record on the page.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page. This update does not change any study details or visible content.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a software/feature update of the page; the change does not modify the study details or displayed data.SummaryDifference0.0%

- Check94 days agoChange DetectedNew navigation/help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and a statement now indicates that the site is no longer looking for participants. The Intervention/Treatment heading formatting was adjusted, and the page's revision tag updated to v3.6.0 (replacing the previous v3.5.5).SummaryDifference0.2%

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.